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indicates frequent local migration. More exten-
sive sampling is necessary to confirm these
results and determine a point of origin.
A community outreach program has been
developed to inform the public about Ae. aegypti
breeding and control in Tucson. Public involve-
ment will be a key factor in the control of these
urban breeders. Major emphasis will also be
placed on programs for children and teachers as
both groups can be instrumental in maintaining
long-term interest in this problem. As these
programs are developed, they can be expanded
and amended to meet the needs of other infested
communities in southern Arizona. A mosquito
control abatement district is under consideration
in a central part of Tucson. The primary purpose
of this district would be to provide approximately
10,000 homeowners with information on control-
ling Ae. aegypti breeding on their property.
Just how long the Ae. aegypti infestation will
last is difficult to assess. Records of the citys
earlier infestation indicate the mosquito was
present for at least a 15-year period (1931 to
1946) (1,3,4). Since their identification in early
1998 summer mosquito samples from Tucson,
adult Ae. aegypti have been part of the citys
local environment for at least  5 consecutive
years (1994 to 1998). Their continued presence
and the abundant breeding habitat provided by
the expansion of Tucsons urban landscape
suggest that Ae. aegypti could survive for an
extended period.
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Can the Military Contribute to Global
Surveillance and Control of Infectious
Diseases?
To the Editor: Numerous networksboth formal
(e.g., Ministries of Health and WHO Collaborat-
ing Centers and collaborating laboratories) and
informal (e.g., nongovernmental and humanitar-
ian organizations, the media, and electronic
discussion groups)contribute to WHOs net-
work of networks for the global surveillance of
infectious diseases (1).
A potential source of additional information
on infectious diseases is the network of military
health facilities and laboratories throughout the
world. In addition to health facilities serving
populations at high risk for infectious diseases,
the military also has laboratories, often among
the better-equipped, in developing countries.
To evaluate the feasibility and potential
usefulness of including military laboratories in
the WHO global surveillance network, we
conducted three surveys.
The first survey identified military laborato-
ries willing to participate in global surveillance
activities and obtained information about their
infectious diseases reporting systems. Of the 107
countries surveyed, 76 replied. Among them, 53
(70%) reported having a central military
laboratory that coordinates laboratory activities
throughout the military, and 62 (82%) reported
that military clinical facilities had a reporting
system for infectious diseases.
The second survey quantified laboratory
capabilities in the 53 laboratories identified in
the first survey and obtained details about the 62
reporting systems. Among the 39 (74%)
laboratories that replied, all can perform at least
one of the following activities: isolating and
identifying bacterial, viral, or parasitic agents.
Twenty-nine (55%) have the capacity for
specialized immunologic or molecular study. In
addition, one of these laboratories has a biosafety
level 4 facility, six have a biosafety level 3
facility, and 10 have a biosafety level 2 facility.
Twenty-seven (51%) of the laboratories perform
compulsory screening of new recruits for HIV, 17
(33%) for hepatitis B, 7 (13%) for hepatitis C, 39
(74%) for tuberculosis, 35 (67%) for syphilis, 18
(34%) for intestinal parasites, 13 (25%) for
schistosomiasis, 12 (23%) for malaria, and 2 (4%)
for Chagas disease.
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Among the 54 reporting systems for which
further information was obtained, clinical
diagnoses (in some countries laboratory con-
firmed) are reported through the hierarchical
chain, normally by mail or facsimile, but in two
countries by electronic links. Almost all military
reporting systems are parallel to civilian
systems. Thirty-four (63%) of 54 systems feed
into the civilian system, with a built-in
mechanism to avoid duplicate reporting; 16
(30%) systems feeding into the civilian system
have no such mechanism in place; and four
have no link with the civilian system.
The third survey addressed vaccination
policies. Among 52 countries that replied, 47
(90%) have a compulsory military vaccination
schedule: 45 (87%) for tetanus, 30 (58%) for
diphtheria, 23 (44%) for typhoid, 16 (31%) for
bacillus Calmette-GuØrin and polio, 12 (23%)
for meningococcal meningitis, and 10 (19%) for
measles, mumps, and rubella.
These surveys show that military popula-
tions are protected against many infectious
diseases and that a wealth of information is
obtained by military laboratories and health-
care facilities on populations at high risk for
infectious diseases. While most of the informa-
tion collected from the health-care facilities is
reported through civilian systems as well,
incorporating the military network of laborato-
ries into the WHO global surveillance network
could ensure broader coverage.
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Dual Infection with Ehrlichia chaffeensis
and a Spotted Fever Group Rickettsia: A
Case Report
To the Editor: In their article, Daniel J. Sexton et
al. state, Well- documented cases of simulta-
neous human infections with more than one tick-
borne pathogen are rare (1) and mention only
two reports of such cases. However, another
report should be mentioned because of its
historical interest and the lessons it may teach.
In 1900 to 1905, in the Bitter Root Valley, a
tick-borne disease emerged, which became
known as Rocky Mountain spotted fever. Although
Ricketts et al. later published a report (2), which
identified the causative agent, in 1904 L.B.
Chowning  and W.M. Wilson published Studies
on Pyroplasma hominis (3). They reported
finding Pyroplasma (since changed to Babesia)
in the blood of approximately 20 patients with
spotted fever. They studied this organism in
detail and even found the reservoir for it in the
local rodent species. Wilson et al. thought that
the organism was the causative agent of spotted
fever. On the basis of their excellent plates and
descriptions, it is clear that the organism they were
describing was what we later came to know as
Babesia microti.
The work of Wilson and Chowning was
ignored and forgotten for many years. They had
incorrectly concluded that spotted fever was
caused by a parasite. For many years it was well
known that Babesia infections became apparent
in human patients only on removal or inactivation
of the spleen. That persons with functional
spleens were subject to infection with B. microti
was finally established by the so-called Nantucket
outbreak (4) and subsequent publications.
Therefore, Wilson and Chownings work
reports several cases of simultaneous infections
of humans by two tickborne pathogens; i.e.,
patients had spotted fever and B. microti in the
blood. More poignant was that an emerging
disease of humans was missed and not
discovered again for some 70 years.
Alexander J. Sulzer
Fellow, American Academy of Microbiology; Fellow,
emeritus, Royal Society of Tropical Medicine and
Hygiene; Member, emeritus, American Society of
Tropical Medicine and Hygiene
References
  1. Sexton DJ, Corey GR, Carpenter C, Kong LQ, Gandhi T,
Breitschwerdt E, et al. Dual infection with Ehrlichia
chaffeensis and a spotted fever group rickettsia: a case
report. Emerg Infect Dis 1998;4:311-6.
  2. Ricketts HT. Some aspects of Rocky Mountain  spotted
fever. Rev Infect Dis 1909;1227-40.
  3. Wilson LB, Chowning WM. Studies on Pyroplasma
hominis. Rev Infect Dis 1904;1:31-57.
  4. Ruebush TK, Juranek DD, Chisholm ES, Snow PC,
Healy GR, Sulzer AJ. Human babesiosis on Nantucket
Island. N Engl J Med 1977;297:825-87.
